Dr.Lankesh Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 30-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 30-12-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.25 Cr
as on 30-12-2024
- Revenue 8.25%
(FY 2022)
- Profit 41.41%
(FY 2022)
- Ebitda 46.58%
(FY 2022)
- Net Worth 152.59%
(FY 2022)
- Total Assets 7.64%
(FY 2022)
About Dr.Lankesh Eye Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹1.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sivarajah Perumal, Sivarajah Lankeswaran, and Annaletchymy Sivarajah serve as directors at the Company.
- CIN/LLPIN
U85110TN2009PTC072865
- Company No.
072865
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2009
- Date of AGM
23 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr.Lankesh Eye Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivarajah Perumal  | Director | 31-Jan-2011 | Current |
| Sivarajah Lankeswaran | Director | 13-May-2022 | Current |
| Annaletchymy Sivarajah | Director | 08-Sep-2018 | Current |
Financial Performance of Dr.Lankesh Eye Hospital.
Dr.Lankesh Eye Hospital Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.25% increase. The company also saw a substantial improvement in profitability, with a 41.41% increase in profit. The company's net worth Soared by an impressive increase of 152.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Lankesh Eye Hospital?
In 2019, Dr.Lankesh Eye Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Slj Enterprises Private LimitedActive 13 years 2 monthsSivarajah Perumal, Sivarajah Lankeswaran and 1 more are mutual person
- L&J Foods Impex Private LimitedActive 12 years 6 months
Sivarajah Perumal, Sivarajah Lankeswaran and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 01 Jun 2010 | ₹1.25 Cr | Satisfied |
How Many Employees Work at Dr.Lankesh Eye Hospital?
Unlock and access historical data on people associated with Dr.Lankesh Eye Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Lankesh Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Lankesh Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
